Director of Myeloma Research

Dr. Berdeja joined Sarah Cannon in 2008 and serves as the director of myeloma research. His responsibilities include seeing patients with all types of blood cancers and patients undergoing blood or marrow transplantation. He is the lead investigator in many clinical trials for patients with blood cancers and has published extensively in the subject.
 


Dr. Berdeja joined Sarah Cannon in 2008 and serves as the director of myeloma research. His responsibilities include seeing patients with all types of blood cancers and patients undergoing blood or marrow transplantation. He is the lead investigator in many clinical trials for patients with blood cancers and has published extensively in the subject.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811